The Effect of Valsartan, Captopril, or Both on Atherosclerotic Events After Acute Myocardial Infarction
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Self-citationA Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
Self-citationMcMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604
Self-citationJulius, S., Kjeldsen, S. E., Weber, M., Brunner, H. R., Ekman, S., Hansson, L., Hua, T., Laragh, J., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16451-9 · Cited by 2,558
Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J.-L., Køber, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032292 · Cited by 2,471
Self-citationJulian, D. G., Moss, A. J., Murray, G. D., Poole-Wilson, P. A., Simoons, M. L., Ball, S., Bender, N., Cleland, J. G. F., Dl, C., Pj, C., et al. (1993) · PubMed · Cited by 2,144
Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., Östergren, J., & Yusuf, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14282-1 · Cited by 1,889
Self-citationJulian, D. G., Moss, A. J., Murray, G. D., Poole-Wilson, P. A., Simoons, M. L., Ball, S., Bender, N., Cleland, J. G. F., Dl, C., Pj, C., et al. (1993) · The Lancet · Cited by 1,860
Gardner, W. P., Mulvey, E. P., & Shaw, E. C. (1995) · Psychological Bulletin · doi:10.1037//0033-2909.118.3.392 · Cited by 1,836
Køber, L., Torp-Pedersen, C., Carlsen, J. E., Bagger, H., Eliasen, P., Lyngborg, K., Videbæk, J., Cole, D. S., Auclert, L., Pauly, N. C., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512213332503 · Cited by 1,773
Self-citationFlather, M. D., Yusuf, S., Køber, L., Pfeffer, M., Hall, A., Murray, G., Torp-Pedersen, C., Ball, S., Pogue, J., Moyé, L., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02212-1 · Cited by 1,585
Self-citationLindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08090-x · Cited by 1,560
McMurray, J. J. V., Östergren, J., Swedberg, K. B., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer (2003) · The Lancet · Cited by 1,043
Self-citationSwedberg, K., Held, P., Kjekshus, J., Rasmussen, K., Rydén, L., & Wedel, H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271002 · Cited by 964
Self-citationYusuf, S., Pepine, C. J., Garces, C., Pouleur, H., Rousseau, M., Salem, D., Kostis, J., Benedict, C., Bourassa, M., & Pitt, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)92889-n · Cited by 666
Angiotensin Receptors and Their Antagonists
Goodfriend, T. L., Elliott, M. E., & Catt, K. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606203342507 · Cited by 558 · cited 1×
“b i b t ( ( r n c p ngiotensin-converting enzyme (ACE) inhibitors and aniotensin receptor blockers (ARBs) are two distinct pharacologic classes that both reduce the actions of angiotenin II at the type 1 receptor (1).”
BackgroundRecent Progress in Angiotensin II Type 2 Receptor Research in the Cardiovascular System
Horiuchi, M., Akishita, M., & Dzau, V. J. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.613 · Cited by 473 · cited 1×
“, fibrinolytic and growth) effects elevant to cardiovascular protection (2,3).”
BackgroundYusuf, S., Pfeffer, Swedberg, K. B., Granger, C. B., Held, P. H., McMurray, J. J. V., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · Cited by 431
Self-citationFliser, D., Buchholz, K., & Haller, H. (2004) · Circulation · doi:10.1161/01.cir.0000140265.21608.8e · Cited by 404
(2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.020 · Cited by 384
Rutherford, J. D., Pfeffer, M. A., Moyé, L. A., Davis, B. R., Flaker, G. C., Kowey, P. R., Lamas, G. A., Miller, H. S., Packer, M., & Rouleau, J. L. (1994) · Circulation · doi:10.1161/01.cir.90.4.1731 · Cited by 331
Self-citationCeriello, A., Assaloni, R., Da Ros, R., Maier, A., Piconi, L., Quagliaro, L., Esposito, K., & Giugliano, D. (2005) · Circulation · doi:10.1161/01.cir.0000165070.46111.9f · Cited by 298
Valsartan in Acute Myocardial Infarction Trial (VALIANT): Rationale and design
Pfeffer, M. A., McMurray, J., Leizorovicz, A., Maggioni, A. P., Rouleau, J.-L., Van de Werf, F., Henis, M., Neuhart, E., Gallo, P., Edwards, S., et al. (2000) · American Heart Journal · doi:10.1067/mhj.2000.108832 · Cited by 184
Self-citationIchiki, T., Takeda, K., Tokunou, T., Iino, N., Egashira, K., Shimokawa, H., Hirano, K., Kanaide, H., & Takeshita, A. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1201.099430 · Cited by 130
Horiuchi, M., Cui, T.-X., Li, Z., Li, J.-M., Nakagami, H., & Iwai, M. (2003) · Circulation · doi:10.1161/01.cir.0000043244.13596.20 · Cited by 107
VALsartan In Acute Myocardial Infarction (VALIANT) Trial: Baseline Characteristics in Context
Velazquez, E. J., Pfeffer, M. A., McMurray, J. V., Maggioni, A. P., Rouleau, J.-L., Van de Werf, F., Kober, L., White, H. D., Swedberg, K., Leimberger, J. D., et al. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00112-0 · Cited by 95
Self-citationLi, Z., Iwai, M., Wu, L., Liu, H., Chen, R., Jinno, T., Suzuki, J., Tsuda, M., Gao, X.-Y., Okumura, M., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000145179.44166.0f · Cited by 88
McMurray, J. J. V., Pfeffer, M. A., Swedberg, K. B., & Dzau, V. J. (2004) · Circulation · doi:10.1161/01.cir.0000147274.83071.68 · Cited by 80
Self-citationCruden, N. L. M., Witherow, F. N., Webb, D. J., Fox, K. A. A., & Newby, D. E. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000129331.21092.1d · Cited by 46 · cited 1×
“, fibrinolytic and growth) effects elevant to cardiovascular protection (2,3).”
BackgroundVALIANT (VALsartan In Acute myocardial iNfarcTion) trial
Maggioni, A. P., & Fabbri, G. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.3.507 · Cited by 37
Self-citationEffects of candesartan on mortality and morbidity in patients with chronic heart failure
Pfeffer, M., Swedberg, K. B., Granger, C. B., Held, P. H., McMurray, J. J. V., Michelson, E. L., Olofsson, B., Östergren, J., Yusuf, S., & Pocock, S. (2003) · Cited by 30
Self-citation
Cited by
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
ST-segment elevation myocardial infarction
Vogel, B., Claessen, B. E., Arnold, S. V., Chan, D., Cohen, D. J., Giannitsis, E., Gibson, C. M., Goto, S., Katus, H. A., Kerneis, M., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0090-3 · Cited by 419
Strauss, M. H., & Hall, A. S. (2006) · Circulation · doi:10.1161/circulationaha.105.594986 · Cited by 249
Bakris, G. L., Sica, D., Weber, M., White, W. B., Roberts, A., Perez, A., Cao, C., & Kupfer, S. (2011) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00425.x · Cited by 143
Demers, C. (2005) · JAMA · doi:10.1001/jama.294.14.1794 · Cited by 78
Metadata
- Authors
- McMurray, J., Solomon, S., Pieper, K., Reed, S., Rouleau, J., Velazquez, E., White, H., Howlett, J., Swedberg, K., Maggioni, A., Køber, L., Van de Werf, F., Califf, R., & Pfeffer, M.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 47
- Issue
- 4
- Pages
- 726-733
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W157136288
- Cited by
- 159
- References
- 34
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.